ERIDEZ-DARNITSA

Selective blocker of peripheral H1 histamine receptors which does not cause sedation

learn more

ERIDEZ-DARNITSA

Selective blocker of peripheral H1 histamine receptors which does not cause sedation

Desloratadine is a selective blocker of peripheral H1 histamine receptors which does not cause sedation. In addition to antihistamine activity desloratadine exerts anti-allergic and anti-inflammatory effect. It has been established that desloratadine inhibits cascade of various reactions being the basis of the allergic inflammation development. Eridez-Darnitsa is indicated for oral use in adults and children aged over 12 years. The medicinal product is used to eliminate symptoms associated with allergic rhinitis (sneezing, nasal discharge, pruritus, oedema and nasal congestion, as well as itching and redness of eyes, watery eyes, itchy palates and coughing), urticaria (pruritus, rash).

More in instructions (Ukrainian version)
INN
desloratadine
Package
5 mg,10 x 500 mg
Form of release
Tablets
Appointment
Skin diseases
АТС class
АТС R06A X27

ERIDEZ-DARNITSA

learn more

  • A modern remedy from allergy

    In May, all major TV channels of the country launched the promotional campaign of ERIDEZ-DARNITSA – an effective medicinal agent to combat allergy for a long term. The campaign will last from May to August – a period of seasonal allergic rhinitis.

See also

See also

Specialized publications intended for medical institutions and doctors Limitations in obtaining information